H Bliesath

A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

J. Novick, Philip B. Miner, Richard A. Krause et al. · Alimentary Pharmacology & Therapeutics · 2002 · 291 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Pharmacokinetics of pantoprazole in man.

Reinhard Huber, M. Hartmann, H Bliesath et al. · PubMed · 1996 · 139 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

Twenty‐four‐hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.

M. Hartmann, U. Theiss, Reinhard Huber et al. · Alimentary Pharmacology & Therapeutics · 1996 · 83 citations

Medicine, Pharmacology, Pharmacotherapy +14

Lack of pantoprazole drug interactions in man: an updated review.

V W Steinijans, Rebekah S. Huber, M. Hartmann et al. · PubMed · 1996 · 72 citations

Medicine, Pharmacokinetics, Pharmacology +15

Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects

Joel Morganroth, Peter C. Rüegg, Cornelia Dunger‐Baldauf et al. · The American Journal of Gastroenterology · 2002 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +17